Short communicationPublished 1 Mar 2024
Persister Cells: A New Perspective on the Development of Castration-Resistant Prostate Cancer?
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Castration-Resistant Prostate Cancer (CRPC) often has genetic alterations in the Androgen Receptor (AR) signaling pathway. Typically, CRPC drugs work by either curbing dihydrotestosterone biosynthesis or impeding AR signaling. In this mini-review, we discuss Drug-Tolerant Persister (DTP), a phenotypic state that is reversible and without genetic mutation on the AR. Persister cells may proffer a new perspective on the development of CRPC.
Keywords
Subjects
Nephrology & UrologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Longdom does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAndrology-Open Access
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Yong Q Chen”
